Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,490,891
+$381,649 QoQ
Shares Held
1,243
+3.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.25%
of 13F equity value
Holder Rank
#2,771
of 4,605 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Davis Investment Partners, LLC holds $18,299,258 across 10 Drug Manufacturers - General names. LLY ranks #5 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
29,096 | $7,389,511 | |
| 2 | ABBV |
AbbVie Inc.
|
10,900 | $2,742,876 | |
| 3 | MRK |
Merck & Co., Inc.
|
13,200 | $1,696,200 | |
| 4 | AMGN |
Amgen Inc
|
4,600 | $1,665,752 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
1,243 | $1,490,891 | |
| 6 | NVS |
Novartis AG
|
5,658 | $886,721 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
15,381 | $886,253 | |
| 8 | BIIB |
Biogen Inc.
|
3,184 | $687,935 |
All Filings in LLY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,490,891 | 1,243 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,109,242 | 1,206 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,282,093 | 1,193 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $832,433 | 1,091 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $850,467 | 1,091 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $927,496 | 1,123 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $819,092 | 1,061 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $759,250 | 857 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $818,463 | 904 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $648,818 | 834 | Shares | Sole | 2024-04-15 | |
| No filing history on record for this holder in this stock. | ||||||